A wind of change in upper gastrointestinal cancers: updates from ESMO 2023
A. Cammarota,
A.R. Siebenhüner,
M.A. Maqueda,
T. Fleitas-Kanonnikoff,
H. van Laarhoven,
C. de la Fouchardière,
R. Obermannova,
M. Moehler,
E.C. Smyth
Affiliations
A. Cammarota
Drug Development Unit, Sarah Cannon Research Institute UK, London, UK
A.R. Siebenhüner
Department of Hematology/Oncology, University Hospital Zurich (USZ), Zurich; Department of Hematology/Oncology, Kantonsspital Schaffhausen, Schaffhausen, Switzerland
M.A. Maqueda
Vall d'Hebron Institute of Oncology (VHIO), Barcelona
T. Fleitas-Kanonnikoff
Medical Oncology, Biomedical Research Institute INCLIVA, Hospital Clínico Universitario, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain
H. van Laarhoven
Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands
C. de la Fouchardière
Institut Paoli-Calmettes, Medical Oncology Department, Marseille, France
R. Obermannova
Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno; Faculty of Medicine, Masaryk University, Brno, Czech Republic
M. Moehler
Department of Internal Medicine, University Cancer Center Mainz, Mainz, Germany
E.C. Smyth
Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK
